阅读说明：本技术 酰化的胰岛素化合物 (Acylated insulin compounds ) 是由 刘�文 A.R.梅佐 F.A.瓦伦佐伊拉 于 2018-05-18 设计创作，主要内容包括：本发明描述的化合物涉及糖尿病和/或高血糖的治疗。更具体地,描述的化合物涉及降低血糖的酰化的胰岛素化合物、含有此类化合物的药物组合物、此类化合物的治疗用途和用于制备所述酰化的胰岛素化合物的中间化合物。(The compounds described herein are related to the treatment of diabetes and/or hyperglycemia. More particularly, the compounds described relate to acylated insulin compounds that lower blood glucose, pharmaceutical compositions containing such compounds, therapeutic uses of such compounds, and intermediate compounds useful in the preparation of said acylated insulin compounds.)